Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

NCT06975514 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: YZJ-1139
DRUG: Zolpidem

Sponsor

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.